AstraZeneca PLC (AZN) 當前追蹤本益比 (P/E) 為 30.3, 前瞻本益比為 19.9. 追蹤盈利收益率為 3.30%, 前瞻盈利收益率 5.03%. PEG 0.03 (Peter Lynch 低估標準 ≤1.0). 葛拉漢數為 $68.74.
本頁證實的標準:
SharesGrow 綜合評分： 64/100 其中 4/7 項標準通過。
| Year | P/E (TTM) | PEG 比率 | P/B 比率 | P/S 比率 | 股息收益率 |
|---|---|---|---|---|---|
| 2016 | 9.7 | 0.40 | 2.29 | 1.48 | 10.45% |
| 2017 | 14.5 | -1.00 | 2.90 | 1.93 | 8.11% |
| 2018 | 22.3 | -0.79 | 3.86 | 2.18 | 7.24% |
| 2019 | 49.2 | -1.25 | 5.00 | 2.69 | 5.47% |
| 2020 | 20.7 | 0.15 | 4.24 | 2.49 | 5.39% |
| 2021 | 733.4 | -7.58 | 2.09 | 2.20 | 4.69% |
| 2022 | 32.1 | 0.01 | 2.85 | 2.38 | 4.14% |
| 2023 | 17.4 | 0.22 | 2.65 | 2.26 | 4.32% |
| 2024 | 14.3 | -0.35 | 2.47 | 1.86 | 4.59% |
| 2025 | 13.3 | 0.07 | 2.79 | 2.32 | 3.74% |
| Year | EPS（稀釋） | 營收 | 淨利潤 | 淨利潤率 |
|---|---|---|---|---|
| 2016 | $1.38 | $23B | $3.5B | 15.2% |
| 2017 | $1.19 | $22.47B | $3B | 13.4% |
| 2018 | $0.85 | $22.09B | $2.16B | 9.8% |
| 2019 | $0.52 | $24.38B | $1.34B | 5.5% |
| 2020 | $1.22 | $26.62B | $3.2B | 12% |
| 2021 | $0.04 | $37.42B | $112M | 0.3% |
| 2022 | $1.06 | $44.35B | $3.29B | 7.4% |
| 2023 | $1.91 | $45.81B | $5.96B | 13% |
| 2024 | $1.13 | $54.07B | $7.04B | 13% |
| 2025 | $13.08 | $58.74B | $10.26B | 17.5% |
| Year | EPS（平均） | EPS 範圍 | 營收（平均） | 營收範圍 | 分析師人數 |
|---|---|---|---|---|---|
| 2026 | $10.29 | $10.12 – $10.59 | $63.02B | $61.42B – $64.06B | 8 |
| 2027 | $11.61 | $11.14 – $12.11 | $67.29B | $64.27B – $68.91B | 8 |
| 2028 | $12.92 | $9.58 – $14.36 | $71.43B | $71.4B – $71.47B | 7 |
| 2029 | $14.39 | $13.51 – $14.91 | $76.44B | $72.81B – $78.54B | 2 |
| 2030 | $16.08 | $15.09 – $16.66 | $81.11B | $77.26B – $83.34B | 5 |
